Growth Metrics

Gilead Sciences (GILD) Treasury Shares (2016 - 2025)

Gilead Sciences filings provide 14 years of Treasury Shares readings, the most recent being $17.8 million for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 18.35% to $17.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.8 million, a 18.35% decrease, with the full-year FY2025 number at $17.8 million, down 18.35% from a year prior.
  • Treasury Shares hit $17.8 million in Q4 2025 for Gilead Sciences, down from $21.8 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $21.8 million in Q4 2024 to a low of $1.0 million in Q2 2022.
  • Median Treasury Shares over the past 5 years was $7.0 million (2021), compared with a mean of $8.9 million.
  • Biggest five-year swings in Treasury Shares: plummeted 85.71% in 2022 and later skyrocketed 600.0% in 2023.
  • Gilead Sciences' Treasury Shares stood at $8.0 million in 2021, then soared by 137.5% to $19.0 million in 2022, then crashed by 31.58% to $13.0 million in 2023, then surged by 67.69% to $21.8 million in 2024, then decreased by 18.35% to $17.8 million in 2025.
  • The last three reported values for Treasury Shares were $17.8 million (Q4 2025), $21.8 million (Q4 2024), and $4.0 million (Q3 2024) per Business Quant data.